Saba Capital Management, L.P. bought HQL
June 24, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 13,812 shares of Abrdn Life Sciences Investors at $14.08 per share, a transaction worth $194.5K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
13,812
Price
$14.08
Total value
$194.5K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJune 24, 2024
Filing dateJune 25, 2024
Shares owned after3,429,891
OwnershipIndirect
10b5-1 planNo
AmendedNo